Qdenga Use In Pregnancy & Lactation

Women of childbearing potential: Women of childbearing potential should avoid pregnancy for at least one month following vaccination. Women who intend to become pregnant should be advised to delay vaccination (see Precautions and Contraindications).
Pregnancy: Animal studies are insufficient with respect to reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions).
There is limited amount of data from the use of Qdenga in pregnant women. These data are not sufficient to conclude on the absence of potential effects of Qdenga on pregnancy, embryo-foetal development, parturition and post-natal development.
Qdenga is a live attenuated vaccine, therefore Qdenga is contraindicated during pregnancy (see Contraindications).
Breast-feeding: It is unknown whether Qdenga is excreted in human milk. A risk to the newborns/infants cannot be excluded.
Qdenga is contraindicated during breast-feeding (see Contraindications).
Fertility: Animal studies are insufficient with respect to reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions).
No specific studies have been performed on fertility in humans.F